Xilio Therapeutics (XLO) FCF Margin (2024 - 2026)
Xilio Therapeutics' (XLO) quarterly FCF Margin came in at 100.48% in Q2 2026, up 8023.0% year-over-year from 1.24% in Q2 2025, and up 44.5% quarter-over-quarter from 181.05% in Q1 2026.
Powered by 
Analysis
Xilio Therapeutics (XLO) FCF Margin (2024 - 2026) Analysis & Trends
Xilio Therapeutics has disclosed FCF Margin across 3 years of filings, most recently posting 100.48% for Q2 2026.
- In Q2 2026, FCF Margin rose 8023.0% year-over-year to 100.48%; the TTM figure through Jun 2026 stood at 95.59% (down 383.0% YoY), while the FY2025 annual figure was 12.59%, up 27767.0% from the prior year.
- FCF Margin came in at 100.48% for Q2 2026 at Xilio Therapeutics, up from 181.05% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 979.04% in Q1 2025 to a low of 821.52% in Q4 2024.
- Average FCF Margin over 3 years is 18.86%, with a median of 100.48% recorded in 2026.
- Year-over-year, FCF Margin soared 80623 bps in 2025 and plunged 116009 bps in 2026.
- Over 3 years, FCF Margin stood at 821.52% in 2024, then soared by 98 bps to 15.29% in 2025, then slumped by 557 bps to 100.48% in 2026.
- Per Business Quant data, the three most recent FCF Margin figures were 100.48% in Q2 2026, 181.05% in Q1 2026, and 15.29% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 34.70% |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 44.00% |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 30.39% |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 13.35% |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -388.28% |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 22.62% |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 14.91% |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -18,629.40% |
| 10 | Xilio Therapeutics | 174.55 Mn | 38.51 Mn | - | -100.48% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -100.48% |
| Mar 31, 2026 | -181.05% |
| Dec 31, 2025 | -15.29% |
| Sep 30, 2025 | -91.76% |
| Jun 30, 2025 | -180.70% |
| Mar 31, 2025 | 979.04% |
| Dec 31, 2024 | -821.52% |
| Sep 30, 2024 | -604.55% |
| Jun 30, 2024 | 846.54% |